Consistent evidence that brain serotonin 2A receptor binding is positively associated with personality-based risk markers of depression.
Where this comes from
- Record sourced from PubMed, PMID 39632615.
- Also identified by DOI 10.1192/bjp.2024.143.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Using [<sup>18</sup>F]altanserin, a serotonin 2A receptor (5-HT<sub>2A</sub>R) antagonist Positron Emission Tomography (PET) tracer, a positive association between cortical 5-HT<sub>2A</sub>R binding and the inward-directed facets of neuroticism has been demonstrated in healthy individuals. Psilocybin, a 5-HT<sub>2A</sub>R agonist, shows promise for the treatment of depression, reducing neuroticism and mood symptoms potentially via hypothalamic-pituitary-adrenal (HPA) modulation. 5-HT<sub>2A</sub>R and neuroticism are both modulated by HPA axis function. In this study, we examined whether the association between 5-HT<sub>2A</sub>R binding and the inward facets of neuroticism can be replicated in an independent healthy cohort using the new 5-HT<sub>2A</sub>R agonist tracer [<sup>11</sup>C]Cimbi-36, and if their association is moderated by cortisol awakening response (CAR), an index of HPA axis function. If so, this could advance mechanistic insights into interventions that target the 5-HT<sub>2A</sub>R and reduce neuroticism. Eighty healthy volunteers underwent [<sup>11</sup>C]Cimbi-36 PET scans and completed the NEO personality inventory (NEO-PI-R) for the assessment of neuroticism. Salivary samples were available for determination of CAR in 70 of the participants. Using linear latent variable models, we evaluated the association between 5-HT<sub>2A</sub>R binding and inward facets of neuroticism, namely depression, anxiety, self-consciousness and vulnerability to stress, and whether CAR moderated this association. The study confirms the positive association between 5-HT<sub>2A</sub>R binding and the inward facets of neuroticism (<i>β</i> = 0.01, 95% CI = [0.0005: 0.02], <i>P</i> = 0.04), and this association is independent of CAR (<i>P</i> = 0.33). The findings prompt consideration of whether novel interventions such as psilocybin that actively targets 5-HT<sub>2A</sub>R and causes changes in personality could be particularly beneficial if implemented as a targeted approach based on neuroticism profiles.
Medical subject headings
- Receptor, Serotonin, 5-HT2A
- Neuroticism
- Brain
- Personality
- Anxiety Disorders
- Depression